Evidence map›Paper›PMID 29129929›Full record

ArticleNature communications2017

IL-2 imprints human naive B cell fate towards plasma cell through ERK/ELK1-mediated BACH2 repression.

Nicolas Hipp, Hannah Symington, Cédric Pastoret, Gersende Caron, Céline Monvoisin, Karin Tarte, Thierry Fest, Céline Delaloy

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 1 synthesis or guideline pooled it, 105 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. A single-cell cytokine dictionary of human peripheral blood.bioRxiv : the preprint server for biology · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. IL-2Rα is dispensable for murine B cell development and humoral response.Journal of immunology (Baltimore, Md. : 1950) · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. EfficientImmune network · 2024
    Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Nicolas HippUMR U1236, Université de Rennes 1, INSERM, Etablissement Français du Sang (EFS) de Bretagne, Equipe labellisée Ligue contre le Cancer, Labex IGO, 2 Av du Pr Léon Bernard, 35043, Rennes, France.
Hannah SymingtonUMR U1236, Université de Rennes 1, INSERM, Etablissement Français du Sang (EFS) de Bretagne, Equipe labellisée Ligue contre le Cancer, Labex IGO, 2 Av du Pr Léon Bernard, 35043, Rennes, France.
Cédric PastoretUMR U1236, Université de Rennes 1, INSERM, Etablissement Français du Sang (EFS) de Bretagne, Equipe labellisée Ligue contre le Cancer, Labex IGO, 2 Av du Pr Léon Bernard, 35043, Rennes, France.
Gersende CaronUMR U1236, Université de Rennes 1, INSERM, Etablissement Français du Sang (EFS) de Bretagne, Equipe labellisée Ligue contre le Cancer, Labex IGO, 2 Av du Pr Léon Bernard, 35043, Rennes, France.
Céline MonvoisinUMR U1236, Université de Rennes 1, INSERM, Etablissement Français du Sang (EFS) de Bretagne, Equipe labellisée Ligue contre le Cancer, Labex IGO, 2 Av du Pr Léon Bernard, 35043, Rennes, France.
Karin TarteUMR U1236, Université de Rennes 1, INSERM, Etablissement Français du Sang (EFS) de Bretagne, Equipe labellisée Ligue contre le Cancer, Labex IGO, 2 Av du Pr Léon Bernard, 35043, Rennes, France.ORCID http://orcid.org/0000-0002-6809-917X
Thierry FestUMR U1236, Université de Rennes 1, INSERM, Etablissement Français du Sang (EFS) de Bretagne, Equipe labellisée Ligue contre le Cancer, Labex IGO, 2 Av du Pr Léon Bernard, 35043, Rennes, France. thierry.fest@univ-rennes1.fr.
Céline DelaloyUMR U1236, Université de Rennes 1, INSERM, Etablissement Français du Sang (EFS) de Bretagne, Equipe labellisée Ligue contre le Cancer, Labex IGO, 2 Av du Pr Léon Bernard, 35043, Rennes, France. celine.delaloy@univ-rennes1.fr.ORCID http://orcid.org/0000-0003-1510-6484
Inserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plasma cell differentiation is a tightly regulated process that requires appropriate T cell helps to reach the induction threshold. To further understand mechanisms by which T cell inputs regulate B cell fate decision, we investigate the minimal IL-2 stimulation for triggering human plasma cell differentiation in vitro. Here we show that the timed repression of BACH2 through IL-2-mediated ERK/ELK1 signalling pathway directs plasma cell lineage commitment. Enforced BACH2 repression in activated B cells unlocks the plasma cell transcriptional program and induces their differentiation into immunoglobulin M-secreting cells. RNA-seq and ChIP-seq results further identify BACH2 target genes involved in this process. An active regulatory region within the BACH2 super-enhancer, under ELK1 control and differentially regulated upon B-cell activation and cellular divisions, helps integrate IL-2 signal. Our study thus provides insights into the temporal regulation of BACH2 and its targets for controlling the differentiation of human naive B cells.

Indexed as

Basic-Leucine Zipper Transcription FactorsCell DifferentiationCells, Culturedets-Domain Protein Elk-1Extracellular Signal-Regulated MAP KinasesGene Regulatory NetworksHumansImmunoglobulin MInterleukin-2Lymphocyte ActivationPlasma CellsPositive Regulatory Domain I-Binding Factor 1RNA InterferenceRNA, Small InterferingSignal TransductionT-LymphocytesBACH2 protein, humanBasic-Leucine Zipper Transcription FactorsELK1 protein, humanets-Domain Protein Elk-1Extracellular Signal-Regulated MAP KinasesIL2 protein, humanImmunoglobulin MInterleukin-2Positive Regulatory Domain I-Binding Factor 1PRDM1 protein, humanRNA, Small InterferingX-Box Binding Protein 1XBP1 protein, human

Identifiers

PMID29129929
PMCPMC5682283
OpenAlexW2767315683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.